MarketCap
Facebook
X
TelegramGeschäftsbericht 2021
hinzugefügt 23.12.2023
Neovasc Betriebsaufwand 2011-2026 | NVCN
Betriebsaufwand Jährlich Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 36.4 M | 31.6 M | 32.6 M | 34.8 M | 138 M | 24.7 M | 21.5 M | 11.1 M | 8.15 M | 5.82 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 138 M | 5.82 M | 34.4 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 38.89 | -0.97 % | $ 5.8 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 8.15 | 4.28 % | $ 585 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 9.67 | 2.87 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.15 | 4.01 % | $ 155 M |  France |
 |
Electromed
ELMD
|
40.3 M | $ 24.4 | 1.73 % | $ 206 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 43.12 | -0.45 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.53 | 0.16 % | $ 121 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
121 M | $ 29.26 | -1.91 % | $ 1.35 B | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.34 | 5.36 % | $ 116 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.52 | -0.82 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Medigus Ltd.
MDGS
|
4.02 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.79 | -1.75 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 182.04 | -0.33 % | $ 13.6 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
367 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.05 | 9.32 % | $ 857 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 113.39 | -0.17 % | $ 197 B | USA |
 |
NuVasive
NUVA
|
777 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
396 M | - | - | $ 217 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.53 | -0.51 % | $ 874 M | Israel |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 72.94 | -1.23 % | $ 108 B | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 105.07 | 0.75 % | $ 1.33 B | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.35 | 18.43 % | $ 1.43 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 13.05 | 0.19 % | $ 1.96 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 85.52 | 0.3 % | $ 50 B | USA |